Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

NeoGenomics Inc

+ Add to Watchlist

NEO:US

5.4600 USD 0.1300 2.44%

As of 20:10:00 ET on 06/01/2015.

Snapshot for NeoGenomics Inc (NEO)

Open: 5.3100 Day's Range: 5.3000 - 5.4600 Volume: 204,791
Previous Close: 5.3300 52wk Range: 3.0100 - 6.1000 1-Yr Rtn: +66.46%

Stock Chart for NEO

No chart data available.
  • NEO:US 5.4300
  • 1D
  • 1M
  • 1Y
5.3300
Interactive NEO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NEO

Current P/E Ratio (ttm) 258.4371
Estimated P/E(12/2015) -
Relative P/E vs. SPX 13.8627
Earnings Per Share (USD) (ttm) 0.0211
Est. EPS (USD) (12/2015) 0.0000
Est. PEG Ratio -
Market Cap (M USD) 329.61
Shares Outstanding (M) 60.37
30 Day Average Volume 213,350
Price/Book (mrq) 5.4764
Price/Sale (ttm) 3.3311
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/17/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NEO

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NEO

NeoGenomics, Inc. operates a network of clinical laboratories that specialize in cancer genetics diagnostic testing services. The Company's services include cytogenetics, fluorescence in-situhybridization (FISH), flow cytometry, morphology, anatomic pathology and molecular genetic testing. NeoGenomics serves pathologists, oncologists, urologists, and hospitals.

Douglas M VanoortChairman/CEOGeorge A CardozaChief Financial Officer
Robert J Shovlin "Rob"Chief Operating OfficerSteven A RossChief Information Officer
More Company Profile & Key Executives for NEO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil